3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
14
Breast Neoplasms
14
Neoplasms
10
Head and Neck Neoplasms
8
Carcinoma, Squamous Cell
8
Lung Neoplasms
7
Leukemia, Myeloid, Acute
7
Glioblastoma
7
Colorectal Neoplasms
7
Ovarian Neoplasms
6
Neoplasm Metastasis
6
Recurrence
5
Pancreatic Neoplasms
5
Melanoma
5
Leukemia
5
Prostatic Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Non-Hodgkin
4
Fallopian Tube Neoplasms
4
Anemia, Refractory, with Excess of Blasts
4
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
3
Rectal Neoplasms
3
Lymphoma, Follicular
3
Colonic Neoplasms
3
Brain Neoplasms
3
Treatment
2
Sarcoma
2
Pleural Effusion, Malignant
2
Pharyngeal Neoplasms
2
Interventions
Everolimus
5
Topotecan
2
Etoposide
2
Cisplatin
2
Bevacizumab
2
veliparib
1
pralsetinib
1
pertuzumab
1
pembrolizumab
1
pasireotide
1
lenvatinib
1
carfilzomib
1
cabozantinib
1
berzosertib
1
Temozolomide
1
Sunitinib
1
Specimen Handling
1
Radiotherapy
1
Radiosurgery
1
Podophyllotoxin
1
Platinum
1
Octreotide
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Irinotecan
1
Ipilimumab
1
Carboplatin
1
Capecitabine
1
CTLA-4 Antigen
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Neuroendocrine
×
Drug Therapy
×
Clear all
No trials found.